Cytodyn preview
Cytodyn favicon

Cytodyn Review

April 2026

$2M
Revenue
26
Employees
8%
Growth
Estimated Revenue
$2M
Total Funding
$90M
Total Employees
26
Employee Growth
8%
Industry
Biotech
About

CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).

Global Rank
N/A

What is Cytodyn's Revenue?

Cytodyn's estimated revenue is $2M.

What does Cytodyn do?

CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).

CompanyRevenueEmployeesGrowthFunding
Gandeeva TherapeuticsGandeeva Therapeutics
$3.8M4917.6%$40M
ImmunoFlexImmunoFlex
$0.2M20.0%N/A
ABOzymes BiomedicalABOzymes Biomedical
$1.6M21-15.0%N/A
Bold TherapeuticsBold Therapeutics
$3.4M2228.6%N/A
UBC BESTUBC BEST
$13.5M874.4%N/A
CytoDynCytoDyn
$2.0M265.0%$89.5M
Industrial PlanktonIndustrial Plankton
$2.8M180.0%N/A
Molecular Testing LabsMolecular Testing Labs
$49.1M31721.5%N/A
DxBilling NowDxBilling Now
$1.1M70.0%N/A
St. Laurent InstituteSt. Laurent Institute
$0.8M533.3%N/A
📊Analytics & Marketing1
☁️Cloud & Hosting1
🎯CSS Frameworks2
🎨JavaScript Libraries1
🎯UI Libraries1
🔧Web Standards2
Tracking & Analytics2
A
Amazon CloudFront
G
Google Analytics

Technology detection powered by advanced web analysis

Powered byTechlist.ai